ArticleGenes & diseases2023

Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site.

Zander Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.